Table 4.

Details on the single-dose clinical studies used for rosuvastatin performance verification

Clinical study	Dose (mg)	Age range (years)	n	% female	Reference
1	10	22–42	11	0	[68]
2	10	31–60	18	0	[54]
3	20	31–60	9	0	[54]
4	40	31–60	9	0	[54]
5	40	21–51	10	0	[8]
6	40	21–39	36	13.9	[14]
7	80	22–44	11	0	[69]
8	80	25–56	14	0	[68]
9	80	29–51	14	0	[70]
10	80	31–60	18	0	[54]
11	80	35–47	20	15	[20]

n number of subjects in each study, % female the female percentage in the study